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Nephron number varies widely between 0.3 and 1.3 million
per kidney in humans. During fetal life, the rate of
nephrogenesis is influenced by local retinoic acid (RA)
level such that even moderate maternal vitamin A deficiency
limits the final nephron number in rodents. Inactivation of
genes in the RA pathway causes renal agenesis in mice;
however, the impact of retinoids on human kidney
development is unknown. To resolve this, we tested for
associations between variants of genes involved in RA
metabolism (ALDH1A2, CYP26A1, and CYP26B1) and kidney
size among normal newborns. Homozygosity for a common
(1 in 5) variant, rs7169289(G), within an Sp1 transcription
factor motif of the ALDH1A2 gene, showed a significant
22% increase in newborn kidney volume when adjusted for
body surface area. Infants bearing this allele had higher
umbilical cord blood RA levels compared to those with
homozygous wild-type ALDH1A2 rs7169289(A) alleles.
Furthermore, the effect of the rs7169289(G) variant was
evident in subgroups with or without a previously reported
hypomorphic RET 1476(A) proto-oncogene allele that is
critical in determining final nephron number. As maternal
vitamin A deficiency is widespread in developing countries
and may compromise availability of retinol for fetal RA
synthesis, our study suggests that the ALDH1A2 rs7169289(G)
variant might be protective for such individuals.
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In humans, nephrogenesis occurs exclusively during fetal life.
As every nephron is linked to a branch of the collecting
system, final nephron number is determined by the extent to
which the ureteric bud arborizes between 4 and 36 weeks
gestation.1 Thus, genetic or environmental factors that alter
the rate of branching nephrogenesis in utero may affect
nephron number and relative kidney size by the time the
baby is born.
Extensive studies of murine kidney development by
Costantini and Shakya2 have shown that ureteric bud branch-
ing is critically dependent on release of glial cell line-derived
neurotrophic factor from the metanephric mesenchyme and
expression of the tyrosine kinase receptor, RET, in cells of the
ureteric bud tip, conferring responsiveness to the glial cell
line-derived neurotrophic factor signal. In response to glial
cell line-derived neurotrophic factor, RET(þ ) cells are
recruited to the ureteric bud tip as it undergoes remodeling
to initiate the next branching event.3 Mice bearing homo-
zygous mutations of the Ret gene are anephric.4 We have
recently identified a common variant, RET1476(A), within an
exonic splicing enhancer of the human RET gene, which
reduces fidelity of normal RET mRNA splicing; babies
carrying this RET variant have 10% decrease in newborn
kidney size.5 Thus, RET expression in ureteric bud tip cells
appears to be a crucial control point for regulation of renal
branching morphogenesis and, thus, final nephron number.
Expression of RET in the ureteric bud tip is exquisitely
sensitive to the paracrine retinoic acid (RA)-dependent
signals from adjacent mesenchymal cells.6 At least one such
RA-responsive secreted branching morphogen, late-gestation
lung protein 1, has been identified.7 Fetal kidney RET expres-
sion is lost when mesenchymal retinoic acid receptors (RARa
and RARb) are knocked out.8 Addition of RA (0.1–1 mM) to
normal embryonic day E14 fetal rat kidney explants
accelerates branching nephrogenesis.9,10
In fetal kidney, RA is synthesized from retinol derived
from the maternal diet and transferred from the placenta
through retinol binding protein in fetal blood. Retinol is
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taken up by a specific receptor (STRA6) on fetal cells
and converted to RA in a two-step enzymatic reaction.
The first step, reversible oxidation of retinol into retinal-
dehyde, involves either alcohol dehydrogenases, or micro-
somal retinol dehydrogenases. The second step, irreversible
oxidation of retinaldehyde into RA, can be catalyzed by
at least four retinaldehyde dehydrogenases (RALDH1, 2, 3,
and 4).11,12 However, enzymatic studies13 and in situ
hybridization14 indicate that RALDH2 is the dominant
enzyme generating RA in embryonic mouse tissues.
Knockout of the Raldh2 gene results in early embryonic
lethality caused by severe trunk, hindbrain, and heart
defects.15,16 The fate of intracellular RA in fetal kidney is
regulated by cytochrome P450 hydroxylases, CYP26A1 and
CYP26B1,17,18 which convert RA into water-soluble hydro-
xylated end-products that are less active and readily
excretable.19,20
Interestingly, adjustments in intracellular RA metabolism
cannot fully compensate for reduced availability of retinol
substrate when maternal dietary vitamin A intake drops
below some threshold. In the early 1950s, Wilson et al.21
observed that maternal vitamin A deficiency in rats
caused renal hypoplasia among the pups and this could be
prevented by vitamin A administration during pregnancy.9
Even mild-to-moderate maternal vitamin A deficiency in
rats (50% reduction in circulating retinol level) causes renal
hypoplasia among the offspring.9 At 14 days of age, the
kidneys of pups exposed to gestational retinol deficiency
weighed 24% less and contained 20% fewer nephrons
than controls.22,23
As rodent nephrogenesis is limited by modest maternal
vitamin A deficiency, we reasoned that optimal kidney
development must require full efficiency of the metabolic
pathways regulating intracellular RA levels. We hypothesized,
therefore, that metabolic bottlenecks due to hypofunctional
genes of the RA pathway might slow ureteric bud branching
and reduce kidney size in utero; conversely, genes with
regulatory elements that confer high expression might
increase branching nephrogenesis. We screened a cohort
of normal Caucasian newborns from Montreal for an
association between polymorphic variants of ALDH1A2
(coding for RALDH2 enzyme), CYP26A1 or CYP26B1 genes
and both: (A) a shift in umbilical cord RA concentration;
(B) a parallel shift in newborn kidney size.
RESULTS
Characteristics of study subjects
Characteristics of the newborn cohort (n¼ 113) are shown in
Table 1. Mean (±s.d.) newborn weight, height, and body
surface area (BSA) were 3.59±0.46 kg, 51.31±2.18 cm, and
0.223±0.018m2, respectively. Unadjusted left, right, and
total kidney volumes were 14.39 (±3.91), 15.93 (±3.68),
and 30.33 (±6.58) ml, respectively. These values are similar
to those of a large cohort of Danish newborns who were
studied within the first 5 days of life.24 Total (leftþ right)
kidney volume corrected for BSA was 135.85 (±27.77)ml/m2.
A polymorphic variant of the human ALDH1A2 gene is
associated with increased newborn renal volume
To define the common variants of ALDH1A2 among
normal Caucasian newborns in Montreal, we genotyped
113 healthy term newborns for 19 known single-nucleotide
polymorphisms (SNPs) spanning the ALDH1A2 gene (Sup-
plementary Table S1). SNP frequencies were similar to those
reported for the Centre d’E´tude du Polymorphisme Humain
(CEPH) population, indicating no appreciable genetic drift
in our cohort. Genotype distributions for each SNP locus
conformed to the expected Hardy–Weinberg equilibrium.
Using an analysis of variance, we detected an association
between total kidney volume normalized to BSA and the
ALDH1A2rs7169289 SNP (p¼ 0.039). A multiple comparisons
testing procedure showed that newborns with homozygosity
for the rs7169289(G), a fairly common variant (minor allele
frequency¼ 20%), had a 22% increase in newborn kidney
volume adjusted for BSA (p¼ 0.023). Total renal volume/BSA
(161ml/m2) among homozygous rs7169289G/G infants
(4.4% of the cohort) was 22% higher than that (132ml/
m2) of subjects who were homozygous for the more common
rs7169289A/A genotype (63.7% of the cohort; (Figure 1)).
Total renal volume/BSA (140ml/m2) in heterozygous
rs7169289A/G infants (31.9% of the cohort) was inter-
mediate between the two homozygous subgroups (Figure 1).
The ALDH1A2rs7169289 SNP is not tightly linked (r2o0.3)
to any of the HapMap SNPs in the 132 kbp ALDH1A2
gene region (chr15:56022918.56155197). We analyzed the
rs7169289 sequence region for transcription factor binding
motifs using two different software programs, TFBIND
(http://tfbind.ims.u-tokyo.ac.jp/) and AliBaba2 (http://www.
generegulation.com/pub/programs/alibaba2/index.html). Both
Table 1 | Characteristics of study subjects
Characteristic Mean value (s.d.) Minimum value Maximum value
Weight (kg) 3.59 (0.46) 2.62 5.05
Height (cm) 51.31 (2.18) 46 58
BSA (m2) 0.223 (0.018) 0.181 0.275
Left kidney volume (ml) 14.39 (3.91) 3.31 23.75
Right kidney volume (ml) 15.93 (3.68) 8.43 28.54
Total kidney volume (ml) 30.33 (6.58) 16.06 47.43
Total kidney volume/BSA (ml/m2) 135.85 (27.77) 80.31 209.61
The mean and s.d. measurements of weight, height, body surface area (BSA), and the left and right kidney volume for the cohort of white newborns (n=113) are presented.
Total kidney volume (left+right) and total kidney volume normalized for BSA are also shown.
Kidney International (2010) 78, 96–102 97
R El Kares et al.: ALDH1A2, newborn retinoic acid and kidney size o r ig ina l a r t i c l e
programs predicted that the ALDH1A2rs7169289 SNP is located
within an Sp1 (Cys2His2 zinc-finger domain) consensus
sequence.
We also genotyped each infant for 13 SNPs covering
the CYP26A1 gene (Supplementary Table S2) and 15 SNPs in
CYP26B1 gene (Supplementary Table S3). However, none of
these polymorphic variants was significantly associated with
newborn kidney volume.
The ALDH1A2rs7169289(G) variant is associated with higher cord
RA levels
If the ALDH1A2rs7169289(G) variant affects newborn kidney
size by increasing local production of RA, we reasoned that
this should be reflected in an increase in RA circulating in
fetal blood.
To quantify levels of RA at the lower end of the spectrum,
we modified a standard high-pressure liquid chromatography
(HPLC) method to ensure clean separation of RA from
retinol and other retinoids. Inspection of cord RA levels
in our cohort demonstrates a skewed distribution with
the appearance of two distinct subgroups: (Group A) two-
thirds of the samples fell below a RA concentration of
10 nmol/l; (Group B) the remaining third of RA values were
spread evenly across a wide range of higher concentrations
(10–550 nmol/l) (Figure 2). Interestingly, retinol levels
(1348 nmol/l) in babies with RA o10 nmol/l were less than
those (862 nmol/l) in babies with RA 410 nmol/l. Umbilical
cord retinol levels were normally distributed in our cohort
(data not shown).
Using a standard two independent proportions test,
we analyzed the relationship between ALDH1A2rs7169289
genotype and cord RA level in the newborn cohort.
Overall, 50% of subjects with RA 410 nmol/l carried the
ALDH1A2rs7169289(G) allele, whereas only 30% of subjects
with RAo10nmol/l carried this allele (po0.001). Also, when
we used the tobit model, we found that mean RA for infants
with one or more ALDH1A2rs7169289(G) alleles (43 nmol/l), was
significantly (p¼ 0.006) higher than cord blood RA in
homozygous ALDH1A2rs7169289(A) subjects (17 nmol/l).
Cord RA level was unrelated to any of the other 19
ALDH1A2 SNPs, which had no association with newborn
kidney volume. Furthermore, cord RA level was uncorrelated
with SNPs in the CYP26A1 or CYP26B1 genes.
The ALDH1A2rs7169289(G) variant is associated with increased
newborn kidney size in subgroups defined by RET1476
genotype
In a previous study, we identified a partially dysfunctional
allele of the RET tyrosine kinase receptor that is associated
with a 10% decrease in newborn kidney volume.5 In this
study we examined the effect of the ALDH1A2rs7169289(G)
variant among babies in whom the hypomorphic
RET1476(A) isoform had been previously identified. Interest-
ingly, in RET1476(A) babies the presence of a single
ALDH1A2rs7169289(G) allele increases newborn kidney volume
from 120 to 135ml/m2 (p¼ 0.044) (Figure 3), bringing it
close to that of babies with wild-type RET alleles (138ml/m2).
We also examined the effect of the ALDH1A2rs7169289(G)
allele among those babies with proven homozygous wild-type
RET alleles. Newborn kidney size of babies with the
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Figure 2 | Levels of retinoic acid (RA) in newborns. Our cohort
demonstrates a skewed distribution with the appearance of two
distinct subgroups: (Group A) two-thirds of the samples (97 out of
145) fell below an RA concentration of 10 nmol/l; (Group B) the
remaining third (48 out of 145) of RA values were spread evenly
across a wide range of higher concentrations (10–550 nmol/l).
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Figure 3 |The ALDH1A2rs7169289(G) variant increases kidney
volume among infants with a dysfunctional RET1476(A) allele.
In RET1476(A) group, the presence of the ALDH1A2rs7169289(G) allele
increases newborn kidney volume from 120 to 135ml/m2.
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Figure 1 | The ALDH1A2 variant (rs7169289G) is associated
with increased newborn renal volume. Kidney volume (KV)/
body surface area (BSA) (161ml/m2) among rs7169289G/G
homozygous infants (4.4% of the cohort) was 22% higher than
that (132ml/m2) of subjects who were homozygous for the more
common rs7169289A/A genotype (63.7% of the cohort;
p¼ 0.023). KV/BSA (140ml/m2) in heterozygous rs7169289A/G
infants (31.9% of the cohort) was intermediate between the two
homozygous subgroups.
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ALDH1A2rs7169289(G/G or G/A)/RET(wildtype) (157ml/m2) was
significantly greater than that of babies with the common
ALDH1A2rs7169289(A/A)/RET(wildtype) genes (133ml/m2)
(p¼ 0.022) (Figure 4).
DISCUSSION
Kidney organogenesis is the result of interactions between the
undifferentiated metanephric blastema and the ureteric bud.
In humans, final nephron number has been determined by
late gestation and displays wide individual variation (0.3–1.3
million nephrons per kidney).25,26 Although once dismissed
as a benign reflection of human diversity, it has been
proposed that individuals born at the low end of the nephron
endowment spectrum may have increased risk for developing
‘essential’ hypertension and renal insufficiency later in life.27
In fact, patients with essential hypertension have 46% fewer
nephrons than normotensive age-matched control subjects.28
We have hypothesized that congenital nephron number is a
multifactorial trait controlled by the interaction of environ-
mental factors (for example, maternal vitamin A intake) and
genetic variants that influence the extent of branching
nephrogenesis during fetal life.
In humans, it is as yet unknown whether maternal retinol
levels influence fetal nephrogenesis as they do in rodents.
However, a pilot study showed that newborn kidney volume
was significantly smaller in Bangalore, India (where maternal
vitamin A deficiency is widespread) than in Montreal (where
most pregnant women are vitamin A replete).29 When
measured in the newborn period, kidney size correlates with
congenital nephron number before the association is masked
by compensatory renal hypertrophy.5 We recently identified a
common variant of the human RET gene that is associated
with relatively small newborn kidney size and function;5
interestingly, RET expression in fetal kidney is exquisitely
sensitive to local RA concentrations.6 This observation
prompted us to consider the possibility that variation in
genes of RA metabolism might also influence nephrogenesis
in fetal life. Specifically, we focussed on the principal genes
involved in the synthesis (ALDH1A2) and degradation
(CYP26A1/CYP26B1) of RA in fetal kidney.
We identified a relatively common (20% of the Montreal
Caucasian population) ALDH1A2 variant, rs7169289(G),
that is associated with a 22% increase in mean newborn
total kidney volume/BSA. It could be that the rs7169289G is
linked to an unidentified variant that regulates RALDH2
expression. However, rs7169289 SNP is located 1.9 kb 30 of
the ALDH1A2 coding elements, within an Sp1 site. Cawley
et al.30 have shown that about one-third of the transcription
factor binding sites that regulate gene expression lie within
introns or 30 to the coding sequence. Thus, we hypothesized
that the rs7169289G variant might increase RALDH2
expression, thereby increasing local RA concentrations in
fetal kidney. Lelie`vre-Pe´gorier et al.9 have shown that a single
injection of RA given to pregnant rats at mid-gestation
induces supernumerary nephrons.
If the ALDH1A2rs7169289(G) variant increases RALDH2
expression in fetal kidney, we reasoned that it might be
reflected by increased levels of RA in umbilical cord blood. To
measure RA in fetal blood, we developed a sensitive HPLC
assay, which allowed quantification in the low range and
overcame the tendancy for retinoids to isomerize and
undergo oxidative degradation during manipulation. In our
cohort of newborns, nearly two-thirds of the umbilical cord
blood samples had RA levels below 10 nmol/l. However,
the distribution was skewed. About one-third of newborns
had fairly high levels of RA, which could not be explained
by high levels of cord blood substrate (retinol). We found
that the ALDH1A2rs7169289(G) allele was significantly asso-
ciated with the high cord RA subgroup. This observation
offers a plausible mechanism by which the ALD-
H1A2rs7169289(G) allele might affect fetal kidney RALDH2
activity, increased RA synthesis and, thus, kidney size.
Furthermore, as RA levels presumably reflect fetal RALDH2
activity, the fact that both newborn RA level and newborn
kidney size were associated with the ALDH1A2rs7169289(G)
allele argues strongly that the two associations were not each
identified by chance.
Two cytochrome P450 hydroxylases (CYP26A1 and
CYP26B1) regulate degradation of RA in fetal kidney. This
is important to protect fetal kidney cells from excessive
RA.19,31 Mice lacking either Cyp26a1 or Cyp26b1 die in utero,
or shortly after birth, and exhibit abnormalities consistent
with those seen in RA teratogenesis. These anomalies include
spina bifida, truncation of the tail, and abnormalities
affecting the kidneys, urogenital tract, and hindgut.32–34
However, no CYP26A1 or CYP26B1 SNP was associated with
either newborn kidney size or cord RA levels. Our study had
80% power to detect a difference in mean kidney volume of
12% or more, assuming a minor allele frequency of 420%
for each SNP.
In a previous study, we identified a RET1476(A) variant
associated with reduced newborn kidney size and increased
cord cystatin C level (reduced renal function).5 Interestingly,
RETexpression in fetal kidney is highly sensitive to local RA.6
We considered the possibility that the ALDH1A2rs7169289(G)
variant might influence kidney size in babies bearing the
KV
/B
SA
 (m
l/m
2 )
200
180
160
140
120
100
80
60
40
20
0
*p=0.022
*
*
133
(N=19)
ALDH1A2 genotype
157
(N =10)
GG/GAAA
Figure 4 | The ALDH1A2rs7169289(G) variant increases kidney
volume among infants with two RET1476(wildtype) alleles.
In RET(wildtype) group, the ALDH1A2rs7169289(G) babies have
significantly greater kidney volume (KV)/body surface area
(BSA) (157ml/m2) than that of babies with the common
ALDH1A2rs7169289(A) allele (133ml/m2) (p¼ 0.02).
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slightly dysfunctional RET1476(A) allele. Our prediction was
confirmed by analyzing the distribution of the rs7169289(G)
variant among babies with the dysfunctional RET1476(A)
variant. The presence of a single ALDH1A2rs7169289(G) allele
influences newborn kidney volume (renal volume/BSA¼
135.4ml/m2), making it likely to be close to that of babies
with wild-type RET alleles (renal volume/BSA¼ 138.6ml/m2).
The effect of the ALDH1A2rs7169289(G) variant was also evident
among the sub-population of babies who were homozygous
for the wild-type RET1476(G) allele. These observations suggest
a robust association between ALDH1A2rs7169289(G) and new-
born kidney size, which is demonstrable even within
independent subgroups of the cohort.
In conclusion, we show that the ALDH1A2rs7169289(G)
variant, present in 20% of healthy Caucasians from Montreal,
is associated with a 22% increase in newborn kidney volume
(adjusted for BSA). The effect of this variant is evident
in subgroups of the study cohort bearing the previously
reported hypomorphic RET1476(A) allele or the most common
(wild-type) RET1476(G) allele. The ALDH1A2rs7169289(G)
variant is also associated with high cord blood RA levels,
suggesting that it influences RALDH2 activity within the fetal
kidney. This represents the first report of a common genetic
variant linked to increased newborn kidney size and could
exert a protective effect in developing countries where
maternal vitamin A deficiency is common.
MATERIALS AND METHODS
Study subjects
Healthy white infants who were born to women with uncomplicated
pregnancies (n¼ 113) were recruited with informed parental
consent at the final prenatal clinical visit to the Royal Victoria
Hospital (Montreal, QC, Canada). The study (PED-04-016) was
approved by the Montreal Children’s Hospital Research Ethics
Board. Mothers with twins, diabetes, intrauterine growth restriction,
genetic abnormalities, renal malformations or hydronephrosis, or
delivery o36 weeks, and who had newborns with low birth weight
(o2500 g) or low serum albumin were excluded. RET1476 genotype
was previously determined on half of the subjects.5
Renal volume
The left and right kidney volumes were measured by ultrasono-
graphy in newborns during the first 48 h of life using the following
formula: (kidney volume¼ 4/3p (length/2) (height/2) (width/2)).
BSA was calculated as the square root of (length (cm) and weight
(kg)/3600) according to Mosteller.35
Cord blood analyses
At birth, cord blood was obtained for isolation of leukocyte DNA
and determination of retinoid levels (retinol and RA). Genomic
DNAwas isolated with the FlexiGene DNA kit (Qiagen, Mississauga,
ON, Canada) according to the manufacturer’s protocol. DNA was
quantified using the Quant-iT PicoGreen dsDNA Assay Kit *2000
(Invitrogen, Carlsbad, CA, USA). To measure retinoids, the cord
blood was collected in a 7ml vacutainer tube containing a silica gel-
based clotting activator, previously wrapped with aluminum foil to
minimize the exposure to light. The blood was immediately
processed in a dark room and serum was collected by centrifugation
at 12,500 g at 41C (AccuSpin Micro R, Fisher Scientific, Toronto,
ON, Canada). Serum samples were stored in 1.5ml brown
Eppendorf cryotubes, coded and stored at 801C until analysis.
We observed that multiple freeze/thaw cycles of the blood
sample resulted in 100% loss of retinoids and that storage at
201C for 1 year resulted in 63% loss of retinoids. Thus, all
samples were stored in the dark at 801C and thawed only once
for analysis.
Extraction of retinoids from cord blood
Retinoids from the blood samples were extracted by butanol/
acetonitrile (equal volumes), essentially as described elsewhere36
except that the method was applied for smaller sample volume. Serum
samples stored at 801C was defrosted on ice and centrifuged for
10min at 41C at 2000 g (Multifuge 3SR Plus, Thermo Scientific,
Ottawa, Ontario, Canada) to obtain a clear supernatant. A volume of
200ml of serum was transferred to a borosilicate tube wrapped in
aluminum foil and 200ml of butanol/acetonitrile (1:1) was added. The
mixture was vortexed for 1min and then added to 72mg of hydrated
K2PO4 in 20ml of water and vortexed again for 30 s. The extraction
mixture was centrifuged at 2000 g for 15min in a Multifuge 3SR Plus
centrifuge pre-cooled to 41C. One hundred microliters of clear
supernatant was injected onto HPLC. Recovery studies were
performed with the addition of retinoids (5–50ng/100ml range) to
three separate cord blood samples.
HPLC analysis of retinoids
For retinoid analysis we used a Shimadzu (Toronto, Ontario, Canada)
LC-10ADVP equipped with a SIL-HTC autosampler and cooling
system (Man-Tech, Guelph, ON, Canada). Retinoids were separated
on a Partisil 10-ODS analytical column (250 4.5mm, Grace
Discovery Sciences, Bannockburn, IL, USA), and eluted with a
mobile phase of acetonitrile/water 65:35, containing 10mM
ammonium acetate, at a flow rate of 1.2ml/min. Retinoids were
detected in a photodiode array detector (Shimadzu Model SPD-M10
AVP) that collected spectra between 200 and 500 nm. Calibration
curves for RA and retinol were obtained using standard pure
solutions of retinoids purchased from Sigma-Aldrich (St Louis, MO,
USA). The purity of retinoid standards were verified by HPLC.
Retinoids were handled under yellow light to prevent photoisome-
rization. HPLC grade solvents were purchased from Fisher Scientific.
Characteristic ultraviolet spectra and retention times identified
each retinoid, and peak areas were measured at lmax-330 in a
Shimadzu SZ-228 data system. The detection limit for retinoids was
2 pg. In this HPLC system, the isomers of RA such as 13-cis/9-cis are
not separated and therefore, the retinoid eluate constitutes a mixture
of RAs.
Choice of SNPs
The NCBI dbSNP database was screened for common coding and
50UTR/30UTR SNPs in ALDH1A2, CYP26A1, and CYP26B1 genes.
Also, haplotype tagging SNPs, with minor allele frequency of 45%
in white populations, were chosen from a region that respectively
spanned ALDH1A2, CYP26A1, and CYP26B1 genes plus 10 kb
at both the 50- and 30-flanking segments, using the HapMap
human genome database (http://hapmap.org/cgi-perl/gbrowse/
hapmap24_B36/). All known SNPs from the CEPH population
(white individuals from Western Europe who settled in Utah) for the
ALDH1A2, CYP26A1, and CYP26B1 gene regions were downloaded
into Haploview (Haploview version 4.1),37 and a plot of linkage
100 Kidney International (2010) 78, 96–102
or ig ina l a r t i c l e R El Kares et al.: ALDH1A2, newborn retinoic acid and kidney size
disequilibrium between SNP was obtained. Using Haploview’s
pairwise ‘Tagger’ program,38 we chose haplotype tagging SNP
(r240.8) that occurred in at least 5% of the population.
SNP genotyping
For each subject, 15 ng of genomic DNA was used for multiplex
genotyping, using Sequenom iPLEX PCR technology (Sequenom,
San Diego, CA, USA). This system involves extension of the PCR
amplicon with modified nucleotides to distinguish SNP alleles by
matrix-assisted laser desorption ionization-time of flight technol-
ogy. Primers for SNP detection were designed using MassARRAY
AssayDesign software (Sequenom, San Diego, CA, USA).
Statistical methods
We analyzed data with R software (http://www.cran.r-project.org,
version 2.7.1). Genotype frequencies for each SNP were examined
for divergence from Hardy–Weinberg equilibrium.39 To investigate
associations between each outcome variable and each SNP, we
performed an analysis of variance by treating genotype as the
dependent variable. When this test yielded a significant difference,
we performed a multiple comparison testing procedure.40
To analyze the relationship between ALDH1A2rs7169289 genotype
and cord RA level in the newborn cohort, we used a standard
two independent proportions test. We also conducted a parametric
test to compare the two independent left-censored samples by
assuming a tobit model as suggested by Zhang et al.41 Such a model
requires the specification of the detection limit; we set this limit
at 0.05 nmol/l.
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